title: Treatment of interferon-induced psychosis in patients with comorbid hepatitis C and HIV.
authors.affiliation: Mount Sinai Medical Center, New York, New York 10029, USA.
authors.forename: Rosalind G
authors.initials: RG
authors.lastname: Hoffman
authors.forename: Mary Ann
authors.initials: MA
authors.lastname: Cohen
authors.forename: César A
authors.initials: CA
authors.lastname: Alfonso
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Weiss
authors.forename: Sian
authors.initials: S
authors.lastname: Jones
authors.forename: Marla
authors.initials: M
authors.lastname: Keller
authors.forename: Juan R
authors.initials: JR
authors.lastname: Condemarín
authors.forename: Nien-Mu
authors.initials: NM
authors.lastname: Chiu
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Jacobson
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D015897:Comorbidity; D003865:Major Depressive Disorder / Q000139:chemically induced / Q000175:diagnosis / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000523:psychology; D012254:Ribavirin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D001569:Benzodiazepines; D010890:Pirenzepine; D012254:Ribavirin; D000077152:Olanzapine